Introduction
Intracranial pressure (ICP) is the pressure which develops first on the skull and eventually in the brain tissue and cerebrospinal fluid (CSF). ICP results in intracranial hypertension eventually. Therefore, ICP needs monitoring to treat severe traumatic brain injury patients. The growing prevalence of neurovascular diseases such as brain aneurysm and arteriovenous malformations (AVMs), favorable reimbursement policies, increasing prevalence of traumatic injuries, and ongoing product developments and commercialization are expected to drive the market growth. According to a study published in the Methodist DeBakey Cardiovascular Journal in 2014, about one million strokes occur annually in the US with 10 to 15% accounting for the intracranial atherosclerotic disease. However, a shortage of trained professionals and high procedural cost of ICP monitoring devices may hamper the growth of the market.
The global intracranial pressure (ICP) monitoring market is expected to reach a market value of USD 2,013.9 million by 2024 from USD 1,160.1 million in 2016 and is expected to register a CAGR of 7.1% during the forecast period from 2016 to 2024. In 2016, the Americas held the highest share of the market at 41.4%, followed by Europe and Asia-Pacific with shares of 33.4% and 20.5%, respectively. Growing technological advancements worldwide are expected to increase the growth of the market during the forecast period.
The global intracranial pressure (ICP) monitoring market is segmented into route of intervention, technique, application, device, end user, and region.
The global intracranial pressure (ICP) monitoring market, by route of intervention, is segmented into intraventricular, epidural sensors, and others.
The global intracranial pressure (ICP) monitoring market, by technique, is segmented into invasive and non-invasive. Invasive techniques are further segmented into external ventricular drainage (EVD) and microtransducer ICP monitoring. Non-invasive techniques are further segmented into transcranial Doppler ultrasonography, tympanic membrane displacement (TMD) analyzer, optic nerve sheath diameter sonography, MRI/CT, and fundoscopy (papilledema).
The global intracranial pressure (ICP) monitoring market, by application, is segmented into traumatic brain injury, intracerebral hemorrhage, meningitis, subarachnoid hemorrhage, and others.
The global intracranial pressure (ICP) monitoring market, by device, is segmented into intraventricular catheters, subarachnoid screws, epidural sensors, non-invasive ICP monitors, and others.
By end user, the global intracranial pressure (ICP) monitoring market is segmented into hospitals and clinics, trauma centers, and others.
Key Players
Integra LifeSciences Corporation, DePuy Synthes, Spiegelberg GmbH & Co. KG, RAUMEDIC Inc, Sophysa SA, Boston Neurosciences, Medtronic Plc, Terumo Corporation, and Natus Medical Incorporated
Study Objectives
> To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the intracranial pressure (ICP) monitoring market
> To provide insights into factors affecting the market growth
> To analyze the global intracranial pressure (ICP) monitoring market based on various tools such as supply chain analysis and Porter's five force analysis
> To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
> To provide country-level analysis of the market with respect to the current market size and future perspective
> To provide country-level analysis of the market for segments by route of intervention, technique, application, device, end user, and region
> To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies and drawing a competitive landscape for the market
> To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the intracranial pressure (ICP) monitoring market
Target Audience
> Brain Monitoring Device Manufacturers & Suppliers
> Contract Research Organizations (CROs)
> Research and Development (R&D) Companies
> Government Research Laboratories
Key Findings
> The global intracranial pressure (ICP) monitoring market is expected to reach USD 2,013.9 million by 2024 at a CAGR of 7.1% from 2016 to 2024
> On the basis of route of intervention, the intraventricular segment accounted for the largest market share at a CAGR of 7.4%
> On the basis of technique, the invasive technique segment accounted for the largest market share at a CAGR of 7.1%
> On the basis of application, traumatic brain injury segment accounted for the largest market share at a CAGR of 7.5%
> On the basis of devices, the intraventricular catheter segment accounted for the largest market share at a CAGR of 7.4%
> On the basis of end user, the hospitals and clinics segment accounted for the largest market share at a CAGR of 7.4%
> The Americas is expected to hold the largest share of the global intracranial pressure (ICP) monitoring market at a CAGR of 7.3% by 2024
> Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 7.4% by 2024
Regional Analysis
> Americas
o North America
? US
? Canada
o South America
> Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
> Asia-Pacific
o Japan
o China
o India
o Australia
o Republic of Korea
o Rest of Asia-Pacific
> Middle East & Africa
o Middle East
o Africa